Surgical Robots Market: Trends and Developments

 The technological advancements in surgical robots, the increasing adoption of surgical robots, the various advantages of robotic-assisted surgery, and the increase in funding for medical robot research are the key drivers of the surgical robots market. Increasing penetration of surgical robots in ASCs and emerging markets are also supporting the growth of this market.

The Surgical Robots Market  is expected to reach USD 11.8 billion by 2025 from USD 6.7 billion in 2020, at a CAGR of 12.1%.

Ask for PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532

Market Segmentation: -

The surgical robots market is segmented based on product & service into robotic systems, instruments & accessories, and services. The instruments & accessories segment is expected to command the largest share of the market in 2020 and is estimated to grow at the highest CAGR during the forecast period. The recurrent purchase of instruments & accessories as opposed to robotic systems, which are a one-time investment, is the major factor driving the growth of this product segment.

The market is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications based on applications. The general surgery applications segment is estimated to command the largest share of the market in 2020, and this segment is also projected to register the highest CAGR owing to increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy.

Market Drivers: -
1 Advantages of Robotic-Assisted Surgery
2 Technological Advancements
3 Increasing Adoption of Surgical Robots
4 Increase in Funding for Medical Robot Research

Regional Analysis: -

North America is expected to dominate the global surgical robots market in 2020, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the increasing demand from key markets such as Japan and China and the large patient population in India. Due to this, the availability of robots has also grown in this region.

Request for Sample Pages - https://www.marketsandmarkets.com/requestsampleNew.asp?id=256618532

Top key Players: -

The major players operating in the surgical robots market include Intuitive Surgical (US), Stryker (US), and Medtronic (Ireland).

 

Stem Cell Therapy Market: Trends and Opportunities

Market growth is driven mainly by factors such as increasing investment in stem cell research and the rising number of GMP-certified stem cell manufacturing plants. However, factors such as ethical concerns and the high cost of stem cell research and manufacturing process likely to hinder the growth of this market.

The global Stem Cell Therapy Market is projected to reach USD 401 million by 2026 from USD 187 million in 2021, at a CAGR of 16.5% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48

Market Segmentation: -

The adipose tissue-derived MSCs segment accounted for the largest share of the cell source segment in the stem cell therapy market in 2020.

Based on the cell source from which stem cells are obtained, the global stem cell therapy market is segmented into four sources. These include adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placenta/umbilical cord-derived MSCs, and other cell sources (which includes human corneal epithelium stem cells, peripheral arterial-derived stem cells, and induced pluripotent stem cell lines). In 2020, adipose tissue-derived MSCs accounted for the markets largest share due to their increasing utilization in treating inflammatory diseases and wounds & injuries. There are several associated advantages, such as ease of harvesting stem cells by minimally invasive methods, simplicity of the isolation procedure, and better quality & proliferation capacity of adipose tissue-derived stem cells.

The musculoskeletal disorders segment accounted for the largest share of the therapeutic application segment in the stem cell therapy  market in 2020

Based on therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and other therapeutic applications (which include ocular diseases, fat loss, and peripheral arterial diseases). In 2020, the musculoskeletal disorders segment accounted for the largest share of the therapeutic application segment. The large market share of this segment is attributed to the increasing prevalence of musculoskeletal disorders such as osteoarthritis, bone repair, and regeneration.

Regional Analysis: -

The Asia Pacific region is the fastest-growing region of the stem cell therapy market in 2020.

The Asia Pacific region is estimated to grow at the highest CAGR in the stem cell therapy market during the forecast period. Some of the major factors fueling the growth of the APAC market include regulatory approvals and guidelines for product approvals and the presence of major stem cell players in countries such as South Korea, Japan, India, and Australia.

Request for Sample Pages  :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=48

Top Key Players: -

Key players in the stem cell therapy market include Smith & Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), and NuVasive, Inc. (US).

COVID-19 Impact on The Pharmaceutical packaging equipment Market Investigated in the latest Research

 The COVID-19 pandemic has largely impacted healthcare delivery globally since December 2019. Due to the coronavirus pandemic, the number of R&D procedures performed in pharmaceutical companies has increased significantly. Scientists and researchers worldwide are engaged in the development of vaccines and drugs for the treatment of coronavirus. This scenario is expected to have a direct impact on the pharmaceutical packaging equipment market. For instance, Syntegon Technology, formerly known as Bosch Packaging Technology, has witnessed an increase in the sales of pharmaceutical packaging equipment due to the coronavirus outbreak across the globe. 

The global Pharmaceutical Packaging Equipment Market size is projected to reach USD 10.4 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 7.4% from 2020 to 2025.

Ask for  PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19845828

Market Segmentation:-

On the basis of product, the pharmaceutical packaging equipment market is segmented into primary packaging equipment, secondary packaging equipment, and labeling and serialization equipment. In 2019, the primary packaging equipment segment accounted for the largest share of the pharmaceutical packaging equipment market. The main function of primary packaging is to restrict climatic, chemical, or biological hazards that cause deterioration. The rising need for the aseptic filling and sealing of drug molecules into sterile containers and the increasing demand for parenteral vials and prefillable syringes are supporting the growth of this segment.

Based on type, the Pharmaceutical Packaging Equipment Industry is segmented into liquid, solid, semi-solid, and other packaging equipment. In 2019, the liquid packaging equipment segment accounted for the largest share of the pharmaceutical packaging equipment market, followed by solid and semi-solid packaging equipment segments.

Key Market Drivers: –
1 High growth in the generics and biopharmaceuticals markets
2 Growing need for flexible and integrated packaging equipment
3 Increase in offshore pharmaceutical manufacturing

Regional Analysis:-

Geographically, the Pharmaceutical Packaging Equipment Industry is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa.

Request for Sample Pages  :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=19845828  

Top Key Players:-

The prominent players in this market are Syntegon Technology (Germany), IMA S.p.A. (Italy), Körber AG (Germany), Uhlmann Group (Germany), OPTIMA Packaging Group (Germany), Romaco Holding (Germany), Marchesini Group (Italy), ACG Worldwide (India), Coesia S.p.A. (Italy) and MULTIVAC Group (Germany).

 

Patient Registry Software Market: Trends and Developments

 The growth of this market is mainly attributed to the shift toward computerized registries from paper-based registries, due to their advantages, is a key driver of market growth. The emergence of the COVID-19 pandemic and the increase in the number of COVID-19 patients globally is also expected to support the demand for patient registry software.

The report Patient Registry Software Market  is projected to reach USD 2.4 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 14.4% from 2020 to 2025.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594

Market Segmentation:-

Based on the type of registry, the patient registry software market is segmented into product registries, health service registries, and disease registries. The disease registries segment accounted for the largest share of 67.2% of the patient registry software market in 2019.

Based on the deployment model, the Patient Registry Software Industry is segmented into on-premise model and cloud-based model. In 2019, on-premise models held 82.6% of the global patient registry software market. The large share of this segment can be attributed to the enhanced control and safety of patient data, and the large number of COVID-19 patients across the globe, which has driven the demand for registries.

Based on functionality, the population health management (PHM) segment accounted for the largest market share of 28.9% in 2019. The large share of this segment can be primarily attributed to the implementation of favorable regulations, such as the ACA in the US.

Based on the end user, the Patient Registry Software Industry is segmented into private payers; hospitals & medical practices; research centers; pharmaceutical, biotechnology, & medical device companies; and government organizations & TPAs. In 2019, the government organizations & TPAs segment accounted for the largest share of 33.9% of the global patient registry software market.

Recent Developments

• In June 2020, ArborMetrix Inc. (US) entered into a partnership with The Society of Interventional Radiology (SIR) (US) . This partnership aims to provide the IR Quality Registry to improve patient care by integrating analytics.
• In April 2020, IQVIA Holdings Inc. (US), announced the launch COVID-19 registry platform and technology-powered trial matching solution
• In March 2020, OpenText Corporation (Canada) acquired XMedius (US) To strengthen OpenText’s leadership in the areas of secure information exchange, unified communications, and digital fax.
• In March 2020, ImageTrend Inc. (US) entered into a partnership with American Heart Association (US) , in this partnership ImageTrend’s Clinical and Research team will analyze pre-hospital data related to heart attacks and strokes in patients during the COVID-19 pandemic.
• InJanuary 2020, M2S . (US) announced the launch Vascular Medicine Consult Registry.

Regional Analysis: -

The patient registry software market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest share of 48.9% of the global patient registry software market.

Request for  Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=144694594

Top key Players: -

Some of the prominent players in this market are Phytel, Inc. (US), IQVIA Holdings, Inc. (US), OpenText Corporation (Canada), ImageTrend, Inc. (US), FIGmd, Inc. (US), Syneos Health Inc. (US) and McKesson Corporation (US).

 

Particle Size Analysis Market to Progress at a Healthy CAGR in Coming Years

 Increasing research activities in the field of nanotechnology, rising investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across industries are fueling the growth of the market. Moreover, increasing government support for nanotechnology research and the rapidly growing pharmaceutical industry in emerging countries are some of the other major factors driving the growth of this market.

The Particle Size Analysis Market  is projected to reach USD 465 million by 2025 from USD 356 million in 2020, growing at a CAGR of 5.5% during the forecast period.

Ask for PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833

Market segmentation: -

Based on technology, the market is segmented into laser diffraction, dynamic light scattering, imaging, coulter principle, nanoparticle tracking analysis, and other technologies. The laser diffraction segment accounted for the largest share of the particle size analysis market in 2019, driven by the growing initiatives to create awareness about laser diffraction, increasing R&D expenditure in the pharma and biotech sectors, and rising food safety concerns.

Based on type, the imaging market is segmented into two major types—dynamic imaging and static imaging.

The Nanoparticle Tracking Analysis (NTA) segment is expected to register the highest growth during the forecast period by technology. The significant growth of this segment is attributed to advanced applications of these particle size analyzers and growing research activities in the field of nanotechnology.

Recent Developments:

• In 2020, MICROTRAC MRB (US) entered into a distribution partnership with ATS Scientific (Canada), where ATS will act as a service provider for MICROTRAC in Canada.
• In 2019, Shimadzu Corporation (Japan), entered into an agreement with Earle A. Chiles Research Institute (Providence), (US). The agreement will focus on the application of mass spectrometry technology to develop tools for personalized cancer immunotherapeutics.
• In 2018, Malvern Panalytical (UK) and Waters Corporation (US) entered into a co-marketing agreement. Under this, both companies will market the polymer characterization product range.

Regional Analysis: -

The particle size analysis industry is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North American region accounted for the largest share of the particle size analysis market in 2019.

Request for Sample Pages : - https://www.marketsandmarkets.com/requestsampleNew.asp?id=74084833

Top Key Players: -

The major players operating in the particle size analyzers market are Malvern Panalytical (UK), HORIBA (Japan), Beckman Coulter, (UK), MICROTRAC MRB, (US), Izon Science (UK), Micromeritics Instrument Corporation (US), Shimadzu Corporation (Japan), Sympatec (Germany), Anton Paar (Austria), TSI (US), Bettersize Instruments (China), FRITSCH (Germany), Brookhaven Instruments, (US), LS Instruments AG (Switzerland), and AimSizer (China).

Ophthalmic Equipment Market to Witness Steady Growth in the Near Future

 The rapid growth in the geriatric population, rising prevalence of eye diseases, and technological advancements in ophthalmic devices are the major factors driving the growth of this market.

The Ophthalmic Equipment Market  size is projected to reach USD 63.3 billion by 2025 from USD 52.8 billion in 2020, at a CAGR of 3.7% during the forecast period.

Ask for PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364

Market Segmentation: -

Based on product, the ophthalmic equipment market is categorized mainly into diagnostic & monitoring devices, surgical devices, and vision care products. In 2019, the vision care products segment was expected to account for the largest share of the ophthalmic equipment market. The large share of this segment can primarily be attributed to the high prevalence of eye disorders such as myopia, hyperopia, astigmatism, and presbyopia. In addition to this, technological advancements in lens materials, growing awareness about eyesight correction, and rising trends in eyewear, such as styled sunglasses and advanced contact lenses boasting extra comfort, have further stimulated the adoption of vision care products.

Recent Developments

• In May 2020, Bausch + Lomb Launched its first EDOF IOL LuxSmart and a monofocal IOL LuxGood with preloaded delivery system and pure refractive optics (PRO) technology.
• In April 2020, Haag-Streit Group (Switzerland) acquired VRmagic Holding AG (Germany) to strengthen Haag-Streit’s leading position in the ophthalmology market
• In February 2020, Bausch + Lomb (Canada)collaborated with Prevent Blindness (US) o raise awareness about AMD through social media pages to share information about AMD with the public.
• In September 2019, Johnson & Johnson Vision Care (US) launched ACUVUE VITA contact lenses for astigmatism in the US
• In February 2019, Carl Zeiss Meditec (Germany)collaborated with Christoffel Mission for the Blind (CBM) (Germany)to open a training center in Pune, India in collaboration with the Poona Blind Men Association

End User: -

Based on end-user, the ophthalmic equipment market is segmented into consumers, hospitals, specialty clinics & ambulatory surgery centers (ASCs), and other end users. specialty clinics & ambulatory surgery centers (ASCs) are expected to grow at the highest CAGR during the forecast period.

Regional Analysis: -

North America is expected to account for the largest share of the ophthalmic equipment market in 2019, followed by Europe. In addition, factor such as the growing awareness and uptake of ophthalmic treatments and surgeries and the availability of advanced ophthalmic devices in this region are also driving the growth of the ophthalmic equipment market in North America.

Request for Sample Pages  :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=155637364    

Top Key Players:-

The prominent players in this market are EssilorLuxottica (France), Alcon (US), Johnson & Johnson Vision Care (US), HOYA Corporation (Japan), Bausch + Lomb (US), Carl Zeiss Meditec (Germany), Topcon (Japan), Glaukos Corporation (US), Haag-Streit (Switzerland), NIDEK (Japan), STAAR Surgical (US), Ziemer Ophthalmic Systems (Switzerland), CooperVision, Inc. (US), Oculentis (Germany), Heidelberg Engineering (Germany), Canon (Japan), Optovue (US), Neo Vision (Korea), Lumenis (Israel), Reichert Technologies (US), OPHTEC BV (Netherlands), Heine Optotechnik (Germany), and Luneau Technology (France).

What is the estimated growth rate of the High-performance Liquid Chromatography (HPLC) Market for the next 5 years?

 The growth in this market is driven by high sensitivity &accuracy of the HPLC technique, the growing importance of HPLC tests in drug approvals, the rising popularity of hyphenated techniques, and increasing pharmaceutical R&D spending. However, the high cost of HPLC systems is expected to restrict market growth to a certain extent.

The report High-performance Liquid Chromatography (HPLC) Market is projected to reach USD 5.7billion by 2025 from USD 4.5billion in 2020, at a CAGR of 4.6% during the forecast period.

Ask for  PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=117899209

Market Segmentation: -

Based on the product, the market was divided into instruments, consumables, and accessories. The instrument market is subjected to account for the largest share in the HPLC market and consumables to growth at the highest rate during the forecast period. The need to analyze compounds in trace concentration and the extensive use of the system in forensic institutes and industries such as pharmaceuticals, food, nutraceuticals, cosmetics, and environmental testing calls for growth of the segment.

Based on the application, the HPLC market is divided into clinical research, diagnostics, forensics, and other applications. Clinical research is subjected to grow at the highest rate in the forecast period. A rise in pharmaceutical and biotechnological research fueled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process is said to drive the market.

Regional Analysis: -

North America is expected to account for the largest share of the global HPLC market. Market growth in this region is driven primarily by the increase in R&D funding, the growing number of preclinical activities by CROs &pharmaceutical companies, and the increasing food & agricultural industry in Canada.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=117899209

Top Key Players:-

The global HPLC market is well established owing to the dominance of prominent market players, such as Waters (US), Agilent (US), Shimadzu (Japan), Thermo Fisher (US), PerkinElmer (US), GE Healthcare (US), Bio-Rad (US), Merck Millipore (Germany), Hitachi (Japan), Showa Denko (Japan), Gilson (US), Phenomenex (US), JASCO (US), Hamilton Company (US), SIELC (US), Orochem (US), YMC Co. Ltd. (Japan), Restek (US), Trajan Scientific (Australia), and Tosoh Bioscience LLC (Japan).

Nucleic Acid Isolation and Purification Market to Witness Steady Growth in the Near Future

 The growth of this market can mainly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. On the other hand, the high cost of automated instruments is expected to hinder the growth of the market.

The Nucleic Acid Isolation and Purification Market  is projected to reach USD 4.8 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period.

Ask for PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229978287

Objectives of the Study

• To define, describe, and forecast the global nucleic acid isolation and purification market by product, method, type, application, end user, and region
• To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, and opportunities)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nucleic acid isolation and purification market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of the nucleic acid isolation and purification market in four major regions along with their respective key countries (North America, Europe, Asia Pacific, and the Rest of the World)
• To profile the key players in the global nucleic acid isolation and purification market and comprehensively analyze their core competencies and market shares
• To track and analyze competitive developments such as product launches, expansions, and R&D activities of the leading players in the nucleic acid isolation and purification market

Market Segmentation: -

On the basis of product, the DNA isolation and purification market has been segmented into kits, reagents, and instruments. The kits segment accounted for the largest share of the global nucleic acid isolation and purification market in 2019.

On the basis of application, the global nucleic acid isolation market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications.

On the basis of type, the global DNA isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types.

Regional Analysis: -

In 2019, North America accounted for the largest share of the nucleic acid isolation and purification market, followed by Europe. The large share of this region can be attributed to factors such as significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region.

Request for Sample Pages : – https://www.marketsandmarkets.com/requestsampleNew.asp?id=229978287

Key Players: -

QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the key players operating in the nucleic acid isolation market.

Needles Market to Witness Steady Growth in the Near Future

 Key factors such growing geriatric population, increasing number of hospitals in emerging markets, and high prevalence of chronic diseases are the major factors driving the growth of the needles market across the globe.

The Needles Market is expected to reach USD 8.47 Billion by 2022, at CAGR of 7.8% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223979930

Market Segmentation:-              

On the basis of type, the global needles market is segmented into two broad categories, namely, conventional needles and safety needles. The conventional needles market is estimated to command the larger share of the global needles market in 2017. The growing demand for biosimilar products, the increasing incidence of chronic disease, and the expanding injectables market are the key factors contributing to the growth of this market segment.

Based on product, the market is segmented into suture needles, blood collection needles, ophthalmic needles, dental needles, insufflation needles, pen needles, and other needles.

The needles market is segmented into hypodermic, intravenous, intramuscular, and intraperitoneal needles on the basis of delivery mode. The hypodermic needles segment is expected to account for the largest share of the needles market in 2017.

Key Market Drivers: –
            1 High Prevalence of Chronic Diseases
            2 Growing Geriatric Population
            3 Increasing Number of Hospitals in Emerging Markets
            4 Increasing Demand for Vaccines

Regional Analysis: -

As of 2016, North America held the largest share of the global needles market, followed by Europe. Its dominant share is attributed to the rising incidence of chronic diseases, initiatives by different organizations for the reduction in blood borne infections and increasing prevalence of cardiovascular diseases.

Request for Sample Pages: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=223979930

Top Key Players: -

The key players in the global needles market are Hamilton Company (U.S.), Medtronic plc (Ireland), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan), Novo Nordisk A/s (Denmark), Smiths Medical (U.K.), and Thermo Fisher Scientific (U.S.).

Stem Cell Therapy Market: Trends and Opportunities

 Market growth is driven mainly by factors such as increasing investment in stem cell research and the rising number of GMP-certified stem cell manufacturing plants. However, factors such as ethical concerns and the high cost of stem cell research and manufacturing process likely to hinder the growth of this market.

The global Stem Cell Therapy Market is projected to reach USD 401 million by 2026 from USD 187 million in 2021, at a CAGR of 16.5% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48

Market Segmentation: -

The adipose tissue-derived MSCs segment accounted for the largest share of the cell source segment in the stem cell therapy market in 2020.

Based on the cell source from which stem cells are obtained, the global stem cell therapy market is segmented into four sources. These include adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placenta/umbilical cord-derived MSCs, and other cell sources (which includes human corneal epithelium stem cells, peripheral arterial-derived stem cells, and induced pluripotent stem cell lines). In 2020, adipose tissue-derived MSCs accounted for the markets largest share due to their increasing utilization in treating inflammatory diseases and wounds & injuries. There are several associated advantages, such as ease of harvesting stem cells by minimally invasive methods, simplicity of the isolation procedure, and better quality & proliferation capacity of adipose tissue-derived stem cells.

The musculoskeletal disorders segment accounted for the largest share of the therapeutic application segment in the stem cell therapy  market in 2020

Based on therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and other therapeutic applications (which include ocular diseases, fat loss, and peripheral arterial diseases). In 2020, the musculoskeletal disorders segment accounted for the largest share of the therapeutic application segment. The large market share of this segment is attributed to the increasing prevalence of musculoskeletal disorders such as osteoarthritis, bone repair, and regeneration.

Regional Analysis: -

The Asia Pacific region is the fastest-growing region of the stem cell therapy market in 2020.

The Asia Pacific region is estimated to grow at the highest CAGR in the stem cell therapy market during the forecast period. Some of the major factors fueling the growth of the APAC market include regulatory approvals and guidelines for product approvals and the presence of major stem cell players in countries such as South Korea, Japan, India, and Australia.

Request for Sample Pages  :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=48

Top Key Players: -

Key players in the stem cell therapy market include Smith & Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd. (Japan), and NuVasive, Inc. (US).

Mycoplasma Testing Market: Trends and Developments

 The global mycoplasma testing markets growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.

The global Mycoplasma Testing Market size is projected to reach USD 1,095 million by 2025 from USD 689 million in 2020, at a CAGR of 9.7%.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136509856

Market Segmentation: -

The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service. In 2019, the assays, kits, & reagents segment accounted for this markets largest share. The frequent purchase of these consumables compared to instruments and the increasing use of kit-based techniques for mycoplasma testing are the essential factors driving this market segments growth.

Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing. In 2019, the cell line testing segment accounted for the largest share of this market. Factors such as the rapid growth in the biopharmaceutical industry and the increasing demand for monoclonal antibodies drive this market segments growth.

Regional Analysis:-

The global mycoplasma testing market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the global mycoplasma testing market. The large share can be attributed primarily to the growth in biotechnology and pharmaceutical industries, the high adoption rate of novel technologies, and the large number of life science research studies conducted in this region.

Recent Developments

• In July 2020, Roche Diagnostics launched Cobas 6800, a fully automated system in India.
• In July 2020, Creative Bioarray launched a full range of cell-based services
• In January 2020, Charles River Laboratories (US) acquired HemaCare Corporation (US)

Request for sample Pages : - https://www.marketsandmarkets.com/requestsampleNew.asp?id=136509856

Top Key Players: -

The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Charles River Laboratories International, Inc. (US), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), American Type Culture Collection (US) and Bionique Testing Laboratories, Inc. (US).

 

Membrane Chromatography Market worth $408 million by 2025 explored in latest Research

 The benefits offered by membrane chromatography over conventional chromatography methods, increasing biopharmaceutical R&D, and increasing regulatory scrutiny on the cleaning validation of downstream purification processes are the major factors driving the growth of the membrane chromatography market.

The report Membrane Chromatography Market  is estimated to grow from USD 198 million in 2020 to USD 408 million by 2025, at a CAGR of 15.5% during the forecast period.

Ask For PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151487196

Market Segmentation:-

Based on product, the membrane chromatography market is segmented into consumables and accessories. The consumables segment is further divided into capsules, cassettes, and cartridges; syringe filters; membrane discs and sheets; spin columns; filter plates; and other consumables (such as pipettes, syringes, vials, and collection plates).

The ion exchange membrane chromatography segment accounted for the largest share of the membrane adsorbers market in 2019. Advantages associated with ion exchange membrane chromatography such as reliability, accuracy and precision, high selectivity and speed, scalability, high separation efficiency, and low cost of consumables and disposables are supporting the growth of this segment.

The flow-through membrane chromatography segment accounted for the largest share of the membrane adsorbers market in 2019.

Based on end user, the global Membrane adsorbers market is segmented into pharmaceutical and biopharmaceutical companies, CROs, and academic and research institutes.

Key Market Drivers: -
            1 Benefits offered by membrane chromatography over conventional chromatography techniques
            2 Increasing biopharmaceutical R&D
            3 Increasing regulatory scrutiny on the cleaning validation of downstream purification processes

Regional Analysis:

In 2019, North America accounted for the largest share of the global Membrane adsorbers market, followed by Europe.

Request for Sample Pages: -  https://www.marketsandmarkets.com/requestsampleNew.asp?id=151487196

Key Market Players:-

The major companies in the global membrane chromatography market are Sartorius AG (Germany), Danaher Corporation (US), Merck Millipore (Germany), Thermo Fisher Scientific (US), and 3M Company (US).